HDFC Sec on Ranbaxy numbers

HDFC Securities VP (Institutional Research) Ranjit Kapadia analyses Ranbaxy's earnings numbers. He believes the guidance of the company is a matter of concern as it is lower than the sales guidance of calendar year 2010.

Related Videos